Steve O'Rahilly has been awarded £2.2 million over 5 years to study Insulin Resistance: Lessons from Extreme Phenotypes, while Krish Chatterjee has funding of £1.8 million to investigate Disorders of nuclear hormone synthesis and action: genetics and pathophysiology.
Speaking about the awards, Sir Mark Walport, Director of the Wellcome Trust, says "We are demonstrating our confidence in these outstanding individuals by providing longer-term, flexible funding; in return, we expect that they will make significant advances in knowledge in their field and act as ambassadors within the research community, helping us achieve our aim of improving human and animal health."
Section:
DOME
